EU Indices slightly down this morning TA focus on Vivendi
European stocks report 20 April 2020: Polymetal | EssilorLuxottica | Vivendi | Philips...
Share this:
INDICES
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
INDICES
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.
EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).
The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate
Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services
Europe worst 3 sectors
utilities, telecommunications, health care
INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).
ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%
MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).
Spot gold remained subdued at $1,680 an ounce.
#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."
Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.
Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.
#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."
Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.
Source: GAIN Capital, TradingView
Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.
#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."
#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.
EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63
Related tags:
Latest market news
Open an account in minutes
Experience award-winning platforms with fast and secure execution, and enjoy tight spreads from 0.5 pts on FX and 0.3 pts on indices.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
USD/MXN Analysis: Is Super Peso Starting to Fade?
Over recent trading sessions, the Mexican peso has continued to show signs of weakness against the U.S. dollar. This can already be seen in USD/MXN, which has gained more than 1.7% over the last three sessions, highlighting sustained buying pressure in favor of the dollar in the short term.
Canadian Dollar Analysis: USD/CAD Returns to July Highs Ahead of NFP
The Canadian dollar continues to face one of its most challenging environments in recent months when it comes to maintaining strength against the U.S. dollar. The weakness of the Canadian currency is clearly reflected in USD/CAD, which has now recorded nine consecutive bullish sessions and gained more than 1.7% during that period.
Gold Price Forecast: XAU/USD Plunges 12.4% Toward Critical Support 10 1 2026
Softer inflation has revived expectations for a Fed pause, but Friday’s payrolls could put gold’s recovery prospects to the test.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.forex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.